<p>This is a $18,963.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to NINDS PHARMAC LLC for medicinal chemistry consulting services. The contract has a Total Small Business set-aside designation. The contract was awarded on January 12, 2017 and has an ultimate completion date of January 12, 2022. The place of performance is Bethesda, Maryland.</p>
This is a $245,400 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to RPK Associates, LLC, a small business, for biological therapeutics product development subject matter expert consulting services. The contract supports the development of therapeutic biotechnology products (biologics) and includes option periods through November 16, 2025. The contract was awarded...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (DHHS) National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Steven Young Consulting LLC, a for-profit consulting services company. The contract, valued at $168,587.14, provides medicinal chemistry consultant support services. The contract is not set aside for a specific business type. The period of performance runs from the award date of February 28, 2018 through...
This is a $156,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Oncolead GMBH & CO. KG, a for-profit limited liability company located in Germany. The contract does not have a set-aside designation and was awarded on September 23, 2015 with a period of performance ending on September 30, 2016. As NIDA is the agency responsible for advancing research on drug use and addiction, this contract is likely supporting the...
This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.
<p>This is a firm fixed-price purchase order awarded by the U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Anderson Paul C, a self-certified small disadvantaged business, for medicinal chemistry consultant support services. The contract has a potential value of $347,835.00 and a completion date of February 27, 2023. The contract is not associated with a larger vehicle and does not have a set-aside designation.</p>
<p>This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Edelris, a for-profit manufacturer, for the delivery of 5,050 proprietary chemical compounds at 1 milligram and 2 x 1 milligram each. The total ceiling value of the contract is $126,150.00, and the ultimate completion date is March 30, 2017. The contract does not have a set-aside designation.</p>
<p>This is a $113,258.16 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian federal agency, to Maris Solutions LLC, a small disadvantaged woman-owned business. The contract has a period of performance ending on February 29, 2016, and was awarded on August 31, 2015. The contract does not have a set-aside designation. The contract award does not reference a larger contract vehicle.</p>
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), awarded a $12,645.00 Firm Fixed Price Delivery Order contract to JP Lawson Consulting, a small business, to provide consulting services under the Drug Consulting Blueprint Network contract vehicle. The contract has no set-aside designation and was awarded on September 21, 2018 with a final completion date of September 27, 2019. JP Lawson Consulting is the sole...
This is a $112,329.81 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Maris Solutions LLC, a self-certified small disadvantaged business, woman-owned small business. The contract does not have a set-aside designation and the ultimate completion date is August 31, 2016. The contract is for unspecified products or services, as the original solicitation was not provided. There is no indication of any major subcontractors or that...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Detke Biopharma Consulting LLC, a for-profit limited liability company, for clinical pharmacology consulting services. The contract has a ceiling value of $29,138.12 and a period of performance ending on January 13, 2022. The contract is not associated with a larger vehicle and does not have a set-aside designation. The contract was awarded on January 12, 2017 under the Major Program Code of "CLINICAL PHARMACOLOGY CONSULTING".